Background
Tetralogy of Fallot (TOF) is one of the most common congenital heart disorders (CHDs). This condition is classified as a cyanotic heart disorder, because tetralogy of Fallot results in an inadequate flow of blood to the lungs for oxygenation (right-to-left shunt) (see the following image). Patients with tetralogy of Fallot initially present with cyanosis shortly after birth, thereby attracting early medical attention.
Anatomic findings in tetralogy of Fallot. Typical features
The 4 features typical of tetralogy of Fallot include right ventricular (RV) outflow tract obstruction (RVOTO) (infundibular stenosis), ventricular septal defect (VSD), aorta dextroposition, and right ventricular hypertrophy. Occasionally, a few children also have an atrial septal defect (ASD), which makes up the pentad of Fallot. The basic pathology of tetralogy is due to the underdevelopment of the right ventricular infundibulum, which results in an anterior-leftward malalignment of the infundibular septum. This malalignment determines the degree of RVOTO.
The clinical features of tetralogy of Fallot are generally typical, and a preliminary clinical diagnosis can almost always be made. Because most infants with this disorder require surgery, it is fortunate that the availability of cardiopulmonary bypass (CPB), cardioplegia, and surgical techniques is now well established. Most surgical series report excellent clinical results with low morbidity and mortality rates.
See also Tetralogy of Fallot With Pulmonary Stenosis, Tetralogy of Fallot With Pulmonary Atresia, and Tetralogy of Fallot With Absent Pulmonary Valve.
Historical information
Louis Arthur Fallot, after whom the name tetralogy of Fallot is derived, was not the first person to recognize the condition. Stensen first described it in 1672; however, it was Fallot who first accurately described the clinical and complete pathologic features of the defects.
Although the disorder was clinically diagnosed much earlier, no treatment was available until the 1940s. Cardiologist Helen Taussig recognized that cyanosis progressed and inevitably led to death in infants with tetralogy of Fallot. She postulated that the cyanosis was due to inadequate pulmonary blood flow. Her collaboration with Alfred Blalock led to the first type of palliation for these infants. In 1944, Blalock operated on an infant with tetralogy of Fallot and created the first Blalock-Taussig shunt between the subclavian artery and the pulmonary artery (see the image below).
This image shows completed blocking with a Taussig shunt The pioneering Blalock-Taussig shunt surgical technique opened a new era in neonatal cardiac surgery. Development of the Potts shunt (from the descending aorta to the left pulmonary artery), the Glenn shunt (from the superior vena cava to the right pulmonary artery), and the Waterston shunt (from the ascending aorta to the right pulmonary artery) followed.
Scott performed the first open correction in 1954. Less than half a year later, Lillehei performed the first successful open repair for tetralogy of Fallot using controlled cross-circulation, with another patient serving as oxygenator and blood reservoir. The following year, with the advent of cardiopulmonary bypass by Gibbons, another historic era of cardiac surgery was established. Since then, numerous advances in surgical technique and myocardial preservation have evolved in the treatment of tetralogy of Fallot.
Anatomy
Patients with tetralogy of Fallot (TOF) can present with a broad range of anatomic deformities. Fallot initially described 4 major defects consisting of[1] : (1) pulmonary artery stenosis, (2) ventricular septal defect (VSD), (3) deviation of the aortic origin to the right, and (4) right ventricular hypertrophy (RV).
In the present day, however, the most important features of tetralogy of Fallot are recognized as (1) the right ventricular (RV) outflow tract obstruction (RVOTO), which is nearly always infundibular and/or valvular, and (2) an unrestricted VSD associated with malalignment of the conal septum (see the following image).
Anatomic findings in tetralogy of Fallot. Right ventricle outflow tract obstruction
Clinically, most patients with tetralogy of Fallot have an increased resistance to right ventricle emptying because of the pulmonary outflow tract obstruction. The anterior displacement and rotation of the infundibular septum causes RV obstruction of variable degree and location. The obstruction may be adjacent to the pulmonary valve, causing additional obstruction.
Pulmonary arteries
The pulmonary arteries can vary in size and distribution, and they may be atretic or hypoplastic. Rarely, the left pulmonary artery is absent. In some individuals, a varying degree of stenosis of the peripheral pulmonary arteries occurs, which further restricts pulmonary blood flow.
Pulmonary atresia results in no communication between the RV and the main pulmonary artery; in this case, pulmonary blood flow is maintained by either the ductus arteriosus or collateral circulation from the bronchial vessels. With minimal RVOTO, pulmonary vascular disease may develop secondary to excessive pulmonary blood flow from the large left-to-right shunt or large aortopulmonary collaterals.
In up to 75% of children with tetralogy of Fallot, some degree of pulmonary valve stenosis may occur. Stenosis is usually due to leaflet tethering rather than commissural fusion. The pulmonary annulus is narrowed in virtually every case.
Aorta
True dextroposition and abnormal rotation of the aortic root result in aortic overriding (ie, an aorta that, to varying degrees, originates from the RV). In some cases, more than 50% of the aorta may thus originate from the RV. A right aortic arch may occur, which may lead to an abnormal origin of the arch vessels.
Associated anomalies
Associated defects are also common. The coexistence of an atrial septal defect (ASD) occurs often enough to prompt its inclusion in a so-called pentalogy of Fallot. Other possible defects include patent ductus arteriosus (PDA), atrioventricular septal defects (AVSD), muscular VSD, anomalous pulmonary venous return, anomalous coronary arteries, absent pulmonary valve, aorticopulmonary window, and aortic incompetence.
The coronary anatomy may also be abnormal. Among these abnormalities is the origin of the left anterior descending (LAD) coronary artery from the proximal right coronary artery (PRCA), which crosses the RV outflow at variable distances from the pulmonary valve annulus. The anomalous LAD coronary artery is observed in 9% of cases of tetralogy of Fallot, and this abnormality makes placement of a patch across the pulmonary annulus risky, possibly requiring an external conduit. During the VSD repair, the anomalous LAD coronary artery is prone to injury. Occasionally, all coronary arteries arise from a single left main coronary ostium.
Etiology and Pathophysiology
The cause(s) of most congenital heart diseases (CHDs) are unknown, although genetic studies suggest a multifactorial etiology. A study from Portugal reported that methylene tetrahydrofolate reductase (MTHFR) gene polymorphism can be considered a susceptibility gene for tetralogy of Fallot.[2, 3]
Prenatal factors associated with a higher incidence of tetralogy of Fallot (TOF) include maternal rubella (or other viral illnesses) during pregnancy, poor prenatal nutrition, maternal alcohol use, maternal age older than 40 years, maternal phenylketonuria (PKU) birth defects, and diabetes. Children with Down syndrome also have a higher incidence of tetralogy of Fallot, as do infants with fetal hydantoin syndrome or fetal carbamazepine syndrome.
As one of the conotruncal malformations, tetralogy of Fallot can be associated with a spectrum of lesions known as CATCH 22 (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, hypocalcemia). Cytogenetic analysis may demonstrate deletions of a segment of chromosome band 22q11 (DiGeorge critical region). Ablation of cells of the neural crest has been shown to reproduce conotruncal malformations.
These abnormalities are associated with the DiGeorge syndrome and branchial arch abnormalities.
The hemodynamics of tetralogy of Fallot depend on the degree of right ventricular (RV) outflow tract obstruction (RVOTO). The ventricular septal defect (VSD) is usually nonrestrictive, and the RV and left ventricular (LV) pressures are equalized. If the obstruction is severe, the intracardiac shunt is from right to left, and pulmonary blood flow may be markedly diminished. In this instance, blood flow may depend on the patent ductus arteriosus (PDA) or bronchial collaterals.
Epidemiology
Tetralogy of Fallot (TOF) represents approximately 10% of cases of congenital heart disease (CHD), occurs in 3-6 infants for every 10,000 births, and is the most common cause of cyanotic CHD. This disorder accounts for one third of all CHD in patients younger than 15 years.
In most cases, tetralogy of Fallot is sporadic and nonfamilial. The incidence in siblings of affected parents is 1-5%, and it occurs more commonly in males than in females. The disorder is associated with extracardiac anomalies such as cleft lip and palate, hypospadias, and skeletal and craniofacial abnormalities. Genetic studies indicate that in some patients with tetralogy of Fallot, there may be 22q11.2 deletion and other submicroscopic copy number alterations.[4]
Tetralogy of Fallot is also observed in other mammals, including horses and rats.
Prognosis
Early surgery is not indicated for all infants with tetralogy of Fallot (TOF), although, without surgery, the natural progression of the disorder indicates a poor prognosis. The progression of the disorder depends on the severity of right ventricular (RV) outflow tract obstruction (RVOTO).
In the present era of cardiac surgery, children with simple forms of tetralogy of Fallot enjoy good long-term survival with an excellent quality of life. Late outcome data suggest that most survivors are in New York Heart Association (NYHA) classification I, although maximal exercise capability is reduced in some.
Sudden death from ventricular arrhythmias has been reported in 1-5% of patients at a later stage in life, and the cause remains unknown. It has been suspected that ventricular dysfunction may be the cause. One study found left ventricular longitudinal dysfunction to be associated with a greater risk of developing life-threatening arrhythmias.[37] Continued cardiac monitoring into adult life is necessary. For some time, it has been suspected that certain children may have inherited a predispostion to developing long QT syndrome. A 2012 study by Chiu confirmed this suspicion.[5]
If left untreated, patients with tetralogy of Fallot face additional risks that include paradoxical emboli leading to stroke, pulmonary embolus, and subacute bacterial endocarditis.
Without surgery, mortality rates gradually increase, ranging from 30% at age 2 years to 50% by age 6 years. The mortality rate is highest in the first year and then remains constant until the second decade. No more than 20% of patients can be expected to reach the age of 10 years, and fewer than 5-10% of patients are alive by the end of their second decade.
Most individuals who survive to age 30 years develop congestive heart failure (CHF), although individuals whose shunts produce minimal hemodynamic compromise have been noted, albeit rarely, and these individuals achieve a normal life span. However, cases of survival of patients into their 80s have been reported. Due to advanced surgical techniques, a 40% reduction in deaths associated with tetralogy of Fallot was noted from 1979 to 2005.[6]
As might be expected, individuals with tetralogy of Fallot and pulmonary atresia have the worst prognoses, and only 50% survive to age 1 year and 8% to age 10 years.
Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. Feb 2005;15 Suppl 1:38-47. [Medline].
Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. Jul-Aug 2009;28(7-8):809-12. [Medline].
Lee CN, Su YN, Cheng WF, Lin MT, Wang JK, Wu MH, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. Dec 2005;84(12):1134-40. [Medline].
Rauch R, Hofbeck M, Zweier C, Koch A, Zink S, Trautmann U, et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet. May 2010;47(5):321-31. [Medline].
Chiu SN, Wu MH, Su MJ, Wang JK, Lin MT, Chang CC, et al. Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired Tetralogy of Fallot are associated with the risks of life-threatening events. Hum Genet. Mar 11 2012;[Medline].
Pillutla P, Shetty KD, Foster E. Mortality associated with adult congenital heart disease: Trends in the US population from 1979 to 2005. Am Heart J. Nov 2009;158(5):874-9. [Medline].
Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. Nov-Dec 2005;25(6):1535-46. [Medline].
Tanel RE. ECGs in the ED. Pediatr Emerg Care. Jun 2007;23(6):428-9. [Medline].
[Guideline] Witte KK, Pepper CB, Cowan JC, Thomson JD, English KM, Blackburn ME. Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot. Europace. Aug 2008;10(8):926-30. [Medline].
Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. Jan 22 2008;117(3):363-70. [Medline].
Senzaki H, Ishido H, Iwamoto Y, Taketazu M, Kobayashi T, Katogi T, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). Jul-Aug 2008;84(4):377-80. [Medline].
Chrysostomou C, Sanchez De Toledo J, Avolio T, Motoa MV, Berry D, Morell VO, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?. Pediatr Crit Care Med. Nov 2009;10(6):654-60. [Medline].
Shepard SM, Tejman-Yarden S, Khanna S, Davis CK, Batra AS. Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med. Jan 2011;39(1):187-9. [Medline].
Al Habib HF, Jacobs JP, Mavroudis C, Tchervenkov CI, O'Brien SM, Mohammadi S, et al. Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg. Sep 2010;90(3):813-9; discussion 819-20. [Medline].
Gustafson RA, Murray GF, Warden HE, Hill RC, Rozar GE Jr. Early primary repair of tetralogy of Fallot. Ann Thorac Surg. Mar 1988;45(3):235-41. [Medline].
Park CS, Lee JR, Lim HG, Kim WH, Kim YJ. The long-term result of total repair for tetralogy of Fallot. Eur J Cardiothorac Surg. Sep 2010;38(3):311-7. [Medline].
Robinson JD, Rathod RH, Brown DW, et al. The evolving role of intraoperative balloon pulmonary valvuloplasty in valve-sparing repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. Dec 2011;142(6):1367-73. [Medline].
Pacifico AD, Kirklin JK, Colvin EV, McConnell ME, Kirklin JW. Transatrial-transpulmonary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg. Jan 1990;2(1):76-82. [Medline].
Lindsey CW, Parks WJ, Kogon BE, Sallee D 3rd, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg. Jan 2010;89(1):147-51. [Medline].
Kanter KR, Kogon BE, Kirshbom PM, Carlock PR. Symptomatic neonatal tetralogy of Fallot: repair or shunt?. Ann Thorac Surg. Mar 2010;89(3):858-63. [Medline].
Tsang FH, Li X, Cheung YF, Chau KT, Cheng LC. Pulmonary valve replacement after surgical repair of tetralogy of Fallot. Hong Kong Med J. Feb 2010;16(1):26-30. [Medline].
Aboulhosn J, Child JS. Management after childhood repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):474-83. [Medline].
Aboulhosn J, Child JS. Management after childhood repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):474-83. [Medline].
Devore GR, Polanko B. Tomographic ultrasound imaging of the fetal heart: a new technique for identifying normal and abnormal cardiac anatomy. J Ultrasound Med. Dec 2005;24(12):1685-96. [Medline].
Duro RP, Moura C, Leite-Moreira A. Anatomophysiologic basis of tetralogy of Fallot and its clinical implications. Rev Port Cardiol. Apr 2010;29(4):591-630. [Medline].
Fox D, Devendra GP, Hart SA, Krasuski RA. When 'blue babies' grow up: What you need to know about tetralogy of Fallot. Cleve Clin J Med. Nov 2010;77(11):821-8. [Medline].
He GW. Current strategy of repair of tetralogy of Fallot in children and adults: emphasis on a new technique to create a monocusp-patch for reconstruction of the right ventricular outflow tract. J Card Surg. Nov-Dec 2008;23(6):592-9. [Medline].
Hörer J, Friebe J, Schreiber C, Kostolny M, Cleuziou J, Holper K, et al. Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. Ann Thorac Surg. Dec 2005;80(6):2285-91. [Medline].
Hövels-Gürich HH, Konrad K, Skorzenski D, Minkenberg R, Herpertz-Dahlmann B, Messmer BJ, et al. Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatr Cardiol. Sep-Oct 2007;28(5):346-54. [Medline].
Kantorova A, Zbieranek K, Sauer H, Lilje C, Haun C, Hraska V. Primary early correction of tetralogy of Fallot irrespective of age. Cardiol Young. Apr 2008;18(2):153-7. [Medline].
Miatton M, De Wolf D, François K, Thiery E, Vingerhoets G. Intellectual, neuropsychological, and behavioral functioning in children with tetralogy of Fallot. J Thorac Cardiovasc Surg. Feb 2007;133(2):449-55. [Medline].
Patel CR, Agamanolis DP, Stewart JW. Prenatal diagnosis of tetralogy of Fallot with obstructed supracardiac totally anomalous pulmonary venous connection. Cardiol Young. Dec 2005;15(6):656-9. [Medline].
Redington AN. Determinants and assessment of pulmonary regurgitation in tetralogy of Fallot: practice and pitfalls. Cardiol Clin. Nov 2006;24(4):631-9, vii. [Medline].
Sakamoto T, Nagase Y, Hasegawa H, Shin'oka T, Tomimatsu H, Kurosawa H. One-stage intracardiac repair in combination with external stenting of the trachea and right bronchus for tetralogy of Fallot with an absent pulmonary valve and tracheobronchomalacia. J Thorac Cardiovasc Surg. Dec 2005;130(6):1717-8. [Medline].
Starr JP. Tetralogy of fallot: yesterday and today. World J Surg. Apr 2010;34(4):658-68. [Medline].
Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med. Apr 14 2012;[Medline].
Diller GP, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, et al. Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults with Repaired Tetralogy of Fallot. Circulation. Apr 11 2012;[Medline].

